The Neonatal and Juvenile Pig in Pediatric Drug Discovery and Development
Pharmacotherapy in pediatric patients is challenging in view of the maturation of organ systems and processes that affect pharmacokinetics and pharmacodynamics. Especially for the youngest age groups and for pediatric-only indications, neonatal and juvenile animal models can be useful to assess drug...
Main Authors: | Miriam Ayuso, Laura Buyssens, Marina Stroe, Allan Valenzuela, Karel Allegaert, Anne Smits, Pieter Annaert, Antonius Mulder, Sebastien Carpentier, Chris Van Ginneken, Steven Van Cruchten |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/1/44 |
Similar Items
-
A Physiology-Based Pharmacokinetic Framework to Support Drug Development and Dose Precision During Therapeutic Hypothermia in Neonates
by: Anne Smits, et al.
Published: (2020-05-01) -
Design and Implementation of an Interdisciplinary Elective Course in Drug Discovery, Development, and Commercialization
by: Williams S. Ettouati, Pharm.D., et al.
Published: (2013-01-01) -
Design and Implementation of an Interdisciplinary Elective Course in Drug Discovery, Development, and Commercialization
by: William S. Ettouati, et al.
Published: (2013-01-01) -
NMR as a “Gold Standard” Method in Drug Design and Discovery
by: Abdul-Hamid Emwas, et al.
Published: (2020-10-01) -
Changing trends in use of hepatocytes and microsomes for evaluating metabolism studies in drug discovery
by: Abdul Naveed Shaik
Published: (2016-06-01)